Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression

Guohe Song,Yang Shi,Meiying Zhang,Shyamal Goswami,Saifullah Afridi,Lu Meng,Jiaqiang Ma,Yi Chen,Youpei Lin,Juan Zhang,Yuming Liu,Zijie Jin,Shuaixi Yang,Dongning Rao,Shu Zhang,Aiwu Ke,Xiaoying Wang,Ya Cao,Jian Zhou,Jia Fan,Xiaoming Zhang,Ruibin Xi,Qiang Gao
DOI: https://doi.org/10.1038/s41421-020-00214-5
IF: 38.079
2020-12-01
Cell Discovery
Abstract:Abstract Diverse immune cells in the tumor microenvironment form a complex ecosystem, but our knowledge of their heterogeneity and dynamics within hepatocellular carcinoma (HCC) still remains limited. To assess the plasticity and phenotypes of immune cells within HBV/HCV-related HCC microenvironment at single-cell level, we performed single-cell RNA sequencing on 41,698 immune cells from seven pairs of HBV/HCV-related HCC tumors and non-tumor liver tissues. We combined bio-informatic analyses, flow cytometry, and multiplex immunohistochemistry to assess the heterogeneity of different immune cell subsets in functional characteristics, transcriptional regulation, phenotypic switching, and interactions. We identified 29 immune cell subsets of myeloid cells, NK cells, and lymphocytes with unique transcriptomic profiles in HCC. A highly complex immunological network was shaped by diverse immune cell subsets that can transit among different states and mutually interact. Notably, we identified a subset of M2 macrophage with high expression of CCL18 and transcription factor CREM that was enriched in advanced HCC patients, and potentially participated in tumor progression. We also detected a new subset of activated CD8 + T cells highly expressing XCL1 that correlated with better patient survival rates. Meanwhile, distinct transcriptomic signatures, cytotoxic phenotypes, and evolution trajectory of effector CD8 + T cells from early-stage to advanced HCC were also identified. Our study provides insight into the immune microenvironment in HBV/HCV-related HCC and highlights novel macrophage and T-cell subsets that could be further exploited in future immunotherapy.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: to gain an in - depth understanding of the complexity of the immune microenvironment in hepatitis B virus (HBV) - and hepatitis C virus (HCV) - related hepatocellular carcinoma (HCC), especially the heterogeneity and dynamic changes of different immune cell subsets. Specifically, researchers hope to evaluate the immune cell diversity in HBV/HCV - related HCC tumors and their non - tumor liver tissues at the single - cell level through single - cell RNA sequencing (scRNA - seq) technology, and reveal specific immune cell subsets related to disease progression. ### Main problems 1. **Heterogeneity and dynamic changes of immune cell subsets**: - Researchers hope to understand the diversity and functional characteristics of different types of immune cells (such as macrophages, NK cells, T cells, etc.) in the tumor microenvironment of HBV/HCV - related HCC. - They also hope to reveal the transcriptional regulation, phenotypic conversion and interaction among these cell subsets. 2. **Specific immune cell subsets related to disease progression**: - Researchers are particularly concerned about those immune cell subsets that are closely related to HCC disease progression, such as new subsets of M2 macrophages and CD8+ T cells. - They hope to provide new targets and strategies for future immunotherapy by identifying these subsets. ### Specific objectives - **Identify and characterize different immune cell subsets**: Through single - cell RNA sequencing, researchers analyzed 41,698 immune cells and identified 29 immune cell subsets with unique transcriptional profiles, including myeloid cells, NK cells and lymphocytes. - **Reveal the functional characteristics of immune cell subsets**: Researchers combined bioinformatics analysis, flow cytometry and multiplex immunohistochemistry to evaluate the functional characteristics, transcriptional regulation, phenotypic conversion and interaction of different immune cell subsets. - **Discover new immune cell subsets related to disease progression**: Researchers discovered an M2 macrophage subset highly expressing CCL18 and the transcription factor CREM, and an activated CD8+ T cell subset highly expressing XCL1. The former is associated with patients with advanced HCC, and the latter is associated with better patient survival rates. ### Conclusion This study provides an in - depth understanding of the immune microenvironment in HBV/HCV - related HCC, especially in terms of the heterogeneity and dynamic changes of immune cell subsets. The research results not only reveal new immune cell subsets related to disease progression, but also provide potential targets and strategies for future immunotherapy.